Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing high sensitivity and specificity, explains Justin Drake, PhD. Current standard ...

Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with ...

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...

Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...

The researchers measured the variation in DNA methylation patterns to develop the method and applied it to multiple types of cancer.

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Cost-effectiveness analysis of population-based screening for 6-gene panel testing for hereditary breast and ovarian cancer. One-year impact of a large-scale pilot multimodal personalized early cancer ...